Ignite Creation Date:
2024-05-06 @ 3:52 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04798677
Status:
COMPLETED
Last Update Posted:
2022-07-21
First Post:
2021-03-12
Brief Title:
Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine
Sponsor:
AB Biotek
Organization:
AB Biotek
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Immunity |
| Vaccine Reaction |
| Influenza |
| Covid19 |
| Cytokine Storm |
| Immunologic Deficiency Syndromes |